These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33053366)

  • 21. A novel endpoint for the assessment of chemotherapy-induced peripheral neuropathy in rodents: biomechanical properties of peripheral nerve.
    Liu CN; Berryman E; Zakur D; Shoieb AM; Pardo ID; Boucher M; Somps CJ; Bagi CM; Cook JC
    J Appl Toxicol; 2018 Feb; 38(2):193-200. PubMed ID: 28815646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
    Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
    Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME
    Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dapsone improves the vincristine-induced neuropathic nociception by modulating neuroinflammation and oxidative stress.
    Shayesteh S; Khalilzadeh M; Takzaree N; Dehpour AR
    Daru; 2022 Dec; 30(2):303-310. PubMed ID: 36104653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life.
    Su YC; Lai YH; Hsieh ST; Teng CJ; Lee YH
    Eur J Oncol Nurs; 2024 Apr; 69():102540. PubMed ID: 38461728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.
    Sands S; Ladas EJ; Kelly KM; Weiner M; Lin M; Ndao DH; Dave A; Vahdat LT; Bender JG
    Support Care Cancer; 2017 Mar; 25(3):701-708. PubMed ID: 27830395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding.
    Ohmura K; Kinoshita T; Tomita H; Okada H; Shimizu M; Mori K; Taniguchi T; Suzuki A; Iwama T; Hara A
    Biochem Biophys Res Commun; 2024 Jan; 691():149286. PubMed ID: 38016339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy.
    Chine VB; Au NPB; Ma CHE
    Neurobiol Dis; 2019 Oct; 130():104492. PubMed ID: 31176721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.
    Madsen ML; Due H; Ejskjær N; Jensen P; Madsen J; Dybkær K
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):471-485. PubMed ID: 31214762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral phrenic nerve plasy: a rare manifestation of vincristine neurotoxicity: correspondence.
    Moriya K; Kakisaka Y; Onuma M; Sasahara Y; Kure S
    Indian J Pediatr; 2014 Dec; 81(12):1429. PubMed ID: 24652272
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.
    Wright GEB; Amstutz U; Drögemöller BI; Shih J; Rassekh SR; Hayden MR; Carleton BC; Ross CJD;
    Clin Pharmacol Ther; 2019 Feb; 105(2):402-410. PubMed ID: 29999516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unilateral phrenic nerve palsy: a rare manifestation of vincristine neurotoxicity.
    Dhingra D; Sethi GR; Mantan M
    Indian J Pediatr; 2014 Sep; 81(9):957-8. PubMed ID: 23801349
    [No Abstract]   [Full Text] [Related]  

  • 34. Unilateral phrenic nerve palsy: a rare manifestation of vincristine neurotoxicity: authors' reply.
    Dhingra D; Sethi GR; Mantan M
    Indian J Pediatr; 2014 Dec; 81(12):1430. PubMed ID: 24652271
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes.
    Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB
    Support Care Cancer; 2024 Apr; 32(5):278. PubMed ID: 38592525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective effect of chemical and natural compounds against vincristine-induced peripheral neuropathy (VIPN).
    Khodaei M; Mehri S; Pour SR; Mahdavi S; Yarmohammadi F; Hayes AW; Karimi G
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Aug; 395(8):907-919. PubMed ID: 35562512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS; Riggs JE
    Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy-induced peripheral neuropathy.
    Quasthoff S; Hartung HP
    J Neurol; 2002 Jan; 249(1):9-17. PubMed ID: 11954874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.
    Wu CY; Li GT; Chu CC; Guo HL; Fang WR; Li T; Wang YR; Xu J; Hu YH; Zhou L; Chen F
    Arch Toxicol; 2023 Feb; 97(2):377-392. PubMed ID: 36418572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome.
    Egan-Sherry D; Bhuta R; Cole PD; Gennarini LM; Kahn JM; Sulis ML; DeNardo BD; Welch JJG
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e997-e999. PubMed ID: 34001785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.